To determine whether emetine could inhibit the Wnt/β-catenin pathway, we analyzed the expression of β-catenin and its downstream targets, c-myc and cyclin D1, after NSCLC cells were treated with or without emetine. Here, CCND1 is linked to non-small cell lung carcinoma.